Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D1T2SQ
|
|||
| Drug Name |
VAC18193
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Respiratory syncytial virus infection [ICD-11: 1C80; ICD-9: 79.6] | Phase 3 | [1] | |
| Company |
JOHNSON & JOHNSON
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05101486) A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to 75 Years. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.